RITA Medical Systems to Present at the C.E. Unterberg, Towbin Emerging Growth Conference
Attendance at the conference is by invitation only. A live webcast of the Company's presentation at the conference will be available via a link provided at the Company's website at www.ritamedical.com. An archived replay of the presentation will begin shortly after the presentation time and will be available for 90 days.
About RITA Medical Systems, Inc.
RITA Medical Systems develops, manufactures and markets innovative products for cancer patients including radiofrequency ablation (RFA) systems for treating cancerous tumors as well as percutaneous vascular and spinal access systems. The Company's oncology product lines include implantable ports, some of which feature its proprietary Vortex® technology; tunneled central venous catheters; safety infusion sets and peripherally inserted central catheters used primarily in cancer treatment protocols. The proprietary RITA system uses radiofrequency energy to heat tissue to a high enough temperature to ablate it or cause cell death. In March 2000, RITA became the first RFA Company to receive specific FDA clearance for unresectable liver lesions in addition to its previous general FDA clearance for the ablation of soft tissue. In October 2002, RITA again became the first company to receive specific FDA clearance, this time, for the palliation of pain associated with metastatic lesions involving bone. The RITA Medical Systems website is at www.ritamedical.com.
SOURCE RITA Medical Systems, Inc.
07/06/2005
CONTACT: investors, +1-415-896-6820, Doug Sherk, dsherk@evcgroup.com, or
Jennifer Beugelmans, or media, Steve DiMattia, +1-646-277-8706, or
sdimattia@evcgroup.com, all of EVC Group, for RITA; or Stephen Pedroff, VP
Marketing Communications of RITA, +1-510-771-0400, or spedroff@ritamed.com
Web site: http://www.ritamedical.com
(RITA)